Top Industry Leaders in the Asia Pacific Lignocaine Market
Latest Asia Pacific Lignocaine Companies Update:
Teva Pharmaceuticals acquires Actavis Group: This strategic move strengthens Teva's presence in the Asia Pacific region and expands their portfolio of lidocaine products.
Pfizer partners with Zuellig Pharma to improve access to essential medicines, including lidocaine, in Southeast Asia: This collaboration aims to leverage Zuellig Pharma's distribution network and local expertise to reach underserved communities.
Sun Pharma introduces a new topical lidocaine cream with enhanced absorption for pain relief: This product targets the growing demand for non-invasive pain management solutions in the region.
AstraZeneca receives approval for their extended-release lidocaine injection in China: This new formulation offers longer-lasting pain relief after surgery and other procedures.
List of Asia Pacific Lignocaine Key companies in the market
- Croma-Pharma GmbH
- Cironpharma, Endo Pharmaceuticals
- ESBA Laboratories
- Sigma-Aldrich
- Swati Spentose Pvt. Ltd.
- Sambria Pharmaceuticals
- Pierrel S.p.A.
- Galen US Inc.
- Mahendra Chemicals
- Iwaki Seiyaku Co., Ltd.
- Biotechnica Pharma Asia Pacific
- Harman Finochem Limited
- Endo International